1. Home
  2. HIT vs MDXH Comparison

HIT vs MDXH Comparison

Compare HIT & MDXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Health In Tech Inc.

HIT

Health In Tech Inc.

HOLD

Current Price

$0.94

Market Cap

74.1M

Sector

Finance

ML Signal

HOLD

Logo MDxHealth SA

MDXH

MDxHealth SA

HOLD

Current Price

$0.69

Market Cap

68.7M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
HIT
MDXH
Founded
1964
2003
Country
United States
Belgium
Employees
N/A
N/A
Industry
Specialty Insurers
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
74.1M
68.7M
IPO Year
2024
2021

Fundamental Metrics

Financial Performance
Metric
HIT
MDXH
Price
$0.94
$0.69
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
3
Target Price
$3.25
$7.67
AVG Volume (30 Days)
71.2K
16.3M
Earning Date
05-12-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
100.00
N/A
EPS
N/A
N/A
Revenue
$33,327,511.00
N/A
Revenue This Year
$41.00
$30.78
Revenue Next Year
$69.63
$18.31
P/E Ratio
N/A
N/A
Revenue Growth
70.99
N/A
52 Week Low
$0.85
$0.40
52 Week High
$4.01
$5.33

Technical Indicators

Market Signals
Indicator
HIT
MDXH
Relative Strength Index (RSI) 37.29 54.12
Support Level $0.93 $0.68
Resistance Level $1.15 $1.13
Average True Range (ATR) 0.05 0.05
MACD -0.00 -0.01
Stochastic Oscillator 9.44 12.58

Price Performance

Historical Comparison
HIT
MDXH

About HIT Health In Tech Inc.

Health In Tech Inc is an AI-enabled insurance technology platform company that offers a marketplace that improves processes in the healthcare industry through vertical integration, process simplification, and automation. By removing friction and complexities, it streamlines the underwriting, sales, and service process for insurance companies, licensed brokers, Managing General Underwriter (MGUs), and third-party administrators (TPAs). The company's platform serves as a marketplace for brokers, TPAs, MGUs and carriers with self-funded health insurance options for employers. The platform includes functions such as plan customization, stop-loss quoting, underwriting, claims administration, and reporting integration.

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.

Share on Social Networks: